|
|
|
|
||
AbbVie to Work On Covid-19 Therapeutic AbbVie to Work On Covid-19 Therapeutic Dow Jones By Matt Grossman AbbVie Inc. will work with three other organizations to develop an antibody therapeutic to prevent and treat Covid-19, the North Chicago, Ill.-based company said Friday. The partnership, with Harbour BioMed, Utrecht University and Erasmus Medical Center, will advance development of a neutralizing antibody already discovered by AbbVie's three collaborators. AbbVie's role will be to prepare for later-stage pre-clinical and development work, the company said. It will receive an option for exclusive licensing of the antibody for development and commercialization world wide. In a lab setting, the antibody blocked cellular infection with SARS-CoV-2, the virus that causes Covid-19, by targeting a region of the virus's spike protein. |
return to message board, top of board |